Amnesia.14 Jan 2013 12:10
I share your enthusiasm for Avacta and believe that the company has a very bright future, but I do feel that your timescale needs a little work.
Avacta describes itself as a consumables and equipment manufacturer, but to sell consumables you first have to have equipment in the field that uses them. AX-1 has the potential to use lots of consumables, but it is still on field trials, hopefully to be fully launched soon. I haven't heard of any new Optim sales recently however I could be wrong there.
The Aptuscan Technology has to be licensed out, which as far as I know hasn't happened yet.
I have heard nothing more on the Pall/ Avacta joint project.
I think that it was EVO that had the license for the diabetes breath test technology, nothing there.
I don't think that we will ever learn any more of the distance gas analysis equipment developed for the MOD.
I also believe that Avacta has yet to make a profit.
So bearing in mind that my up to date info is fairly scant, I doubt that AVCT will reach its full potential this week.
Having said that, I would love to be proved wrong as I have a few mil of these shares.
Bye the way, if anyone does have up to date info I'm sure we would all like to see it.